Profil
Phillip Altman is the founder of Pharmaco Pty Ltd., ARCS Australia Ltd.
He worked as a Non-Executive Director at Viralytics Pty Ltd.
from 2009 to 2014.
Altman received his undergraduate, graduate, and doctorate degrees from The University of Sydney.
Aktive Positionen von Phillip Altman
| Unternehmen | Position | Beginn |
|---|---|---|
| ARCS Australia Ltd. | Gründer | 10.12.2010 |
Ehemalige bekannte Positionen von Phillip Altman
| Unternehmen | Position | Ende |
|---|---|---|
| VIRALYTICS LTD. | Direktor/Vorstandsmitglied | 01.09.2014 |
| Pharmaco Pty Ltd. | Gründer | - |
Ausbildung von Phillip Altman
| The University of Sydney | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 3 |
|---|---|
Viralytics Pty Ltd.
 Viralytics Pty Ltd. BiotechnologyHealth Technology Viralytics Pty Ltd. engages in the development and commercialization of oncolytic immunotherapies that harness the power of certain viruses to infect and kill cancer cells. Its product, CAVATAK, is a genetically unmodified proprietary formulation of the common cold Coxsackievirus Type A21. The company was founded in 1984 and is headquartered in Sydney, Australia. | Health Technology |
| Pharmaco Pty Ltd. | |
| ARCS Australia Ltd. |
